Effect of blonanserin on cognitive impairment in schizophrenic patient-non-blinded, randomized, comparative study with olanzapine
Not Applicable
- Conditions
- schizophrenia
- Registration Number
- JPRN-UMIN000008217
- Lead Sponsor
- Department of Psychiatry, Faculty of Medical Science, Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
blonanserin or olanzapine administration (within 1 month before trial) clozapine prescription (within 3 month before trial) coma seizure disorders,brain organic disease serious complication drug,alcohol abuse diabetes mellitus pregnancy,possibility of pregnancy dementia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BACS-J
- Secondary Outcome Measures
Name Time Method